Adar1 Capital Management, LLC Keros Therapeutics, Inc. Call Options Transaction History
Adar1 Capital Management, LLC
- $1.06 Trillion
- Q3 2025
Call Options
1 transactions
Others Institutions Holding KROS
# of Institutions
170Shares Held
35.4MCall Options Held
574KPut Options Held
325K-
Vanguard Group Inc Valley Forge, PA2.72MShares$46.9 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY2.71MShares$46.7 Million3.92% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$43.4 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.19MShares$37.8 Million10.27% of portfolio
-
Tang Capital Management LLC San Diego, CA1.42MShares$24.5 Million1.02% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $445M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...